Intestinal damage, inflammation and microbiota alteration during COVID-19 infection

A Saviano, M Brigida, C Petruzziello, C Zanza… - Biomedicines, 2023 - mdpi.com
Background: The virus SARS-CoV-2 is responsible for respiratory disorders due to the fact
that it mainly infects the respiratory tract using the Angiotensin-converting enzyme 2 (ACE2) …

Safety and efficacy of probiotic supplements as adjunctive therapies in patients with COVID-19: a systematic review and meta-analysis

J Zhu, T Pitre, C Ching, D Zeraatkar, S Gruchy - PLoS One, 2023 - journals.plos.org
Background and aims Oral probiotic supplementation may be a beneficial adjunctive
therapy for patients with symptomatic COVID-19. However, its safety and efficacy are …

The Possible Role of Probiotics in Combating COVID-19

G Darmawan, M Tendean, A Dharmawan… - … Indonesian Journal of …, 2020 - ina-jghe.com
Since first reported in Wuhan in the end of 2019, COVID-19 infection has spread globally.
However, our battle against COVID-19 is still limited with treatment modalities, yet giving a …

COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?

MA Shahrbaf, M Hassan, M Vosough - Expert Review of …, 2022 - Taylor & Francis
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan, China, and …

Association of dietary inflammatory index and the SARS-CoV-2 infection incidence, severity and mortality of COVID-19: a systematic review and dose-response meta …

X Hao, S Li, Y Yang, H Dai, Y Yan, D Li - Nutrition Journal, 2024 - Springer
Background Several studies have reported the association between dietary inflammatory
index (DII) and the SARS-CoV-2 infection risk, severity or mortality of COVID-19, however …

[HTML][HTML] Advances in the interaction between intestinal microbiota and COVID-19

ZJ He, YX Liang, LY Cai - Exploratory Research and …, 2021 - xiahepublishing.com
Abstract Coronavirus disease 2019 (COVID-19) is a global epidemic disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many digestive symptoms …

Gut microbiota alteration and its association with immune function in post-COVID-19 patients

J Cai, J Xu, Y Tan, Y Xiang, Z Li, J Zheng, Y Li - Folia Microbiologica, 2024 - Springer
To reveal the variation of gut microbiota and its association with immune function in cured
patients with coronavirus 2019 (COVID-19) disease, gut microbiota of patients discharged …

A randomised, double-blind, placebo-controlled trial evaluating concentrated phytochemical-rich nutritional capsule in addition to a probiotic capsule on clinical …

R Thomas, M Williams, J Aldous, Y Yanagisawa… - COVID, 2022 - mdpi.com
Gut microflora dysbiosis affects the majority of individuals after COVID-19, contributing to
both gastro-intestinal (GI) and non-GI symptoms. Natural phytochemicals have reported anti …

Post-COVID-19 irritable bowel syndrome-importance of diet therapy and probiotic therapy.

D Grońska, K Drzewowska - 2022 - cabidigitallibrary.org
Abstract Introduction and Objective: The current challenge for medicine and the related
disciplines is the development of methods and algorithms for dealing with the development …

[HTML][HTML] Inflammatory effect on the gastrointestinal system associated with COVID-19

P Delgado-Gonzalez… - World Journal of …, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that causes
coronavirus disease-2019 (COVID-19) has provoked a global pandemic, mainly affecting …